Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00195156 · ClinicalTrials.gov registry record · Phase 1
Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 1
- Development phase
NCT00195156: Clinical Trial Phase 1 study, sponsored by Weill Medical College of Cornell University.
NCT00195156 is a Phase 1 study that was terminated before completion, run by Weill Medical College of Cornell University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00195156, a Phase 1 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to find out the highest tolerated dose of Depakote in combination with liposome encapsulated all-trans retinoic acid (ATRA-IV) in patients with advanced solid tumor malignancies.
Interventions
- DRUG ATRA-IV
- DRUG Depakote
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-07 |
| Phase | Phase 1 |
Why NCT00195156 stopped before completion
NCT00195156 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which ATRA-IV is the first listed.
NCT00195156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00195156 about?
NCT00195156 is a clinical study titled "Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies". The purpose of this study is to find out the highest tolerated dose of Depakote in combination with liposome encapsulated all-trans retinoic acid (ATRA-IV) in patients with advanced solid tumor malignancies.
What is the current status of trial NCT00195156?
This trial is currently terminated. It is a Phase 1 study. The study started on 2003-07.
What interventions are being tested in trial NCT00195156?
The interventions under investigation include: ATRA-IV (DRUG), Depakote (DRUG).
Who is sponsoring clinical trial NCT00195156?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia